Organization

Tel Aviv Medical Center

3 clinical trials

5 abstracts

Abstract
Phase 3 TRIDENT study (EF-32): Tumor treating fields (TTFields; 200 kHz) concomitant with chemoradiation, and maintenance TTFields therapy/temozolomide in newly diagnosed glioblastoma.
Org: Novocure Inc., Thomas Jefferson University, University of Montreal, Johns Hopkins University School of Medicine, Tufts Medical Center/Tufts University,
Abstract
Survival-inferred fragility index of FDA-approved cancer drugs using surrogate endpoints.
Org: Davidoff Cancer Center, Rabin Medical Center–Beilinson Hospital, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Medical Center,
Abstract
Celiac plexus radiosurgery for pain management in advanced cancer: An international phase II trial, health-related quality of life (HRQOL) outcomes.
Org: Sheba Medical Center, Or-Yeuda, Ramat Gan, Israel, Israeli Medical Research Center, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice,
Abstract
AUTOANTIBODY PROFILES IN PATIENTS WITH ACTIVE LUNG TUBERCULOSIS
Org: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Tel Aviv Medical Center, Geriatrics, Addenbrookes Hospital, Cambridge, United Kingdom, Tuberculosis Research Centre, Shmuel-Harofeh Geriatric Medical Center,